Clinical Trials
Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118
Valeant Pharmaceuticals International, Inc. announced positive results from a second confirmatory pivotal Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study to assess the safety...
Press Releases
Dolomite Bio launches Injection Valve and Sample Loop for scRNA-Seq
Dolomite Bio has launched a new Injection Valve and Sample Loop for single cell RNA sequencing workflows. This option enables straightforward, gentle introduction of evenly...
Clinical Trials
Clinerion enters South America, as Brazil’s iHealth Group joins the Patient Recruitment System platform
The iHealth Group of Brazil joins the Patient Recruitment System platform as Clinerion's first hospital cluster in South America. iHealth brings...
Press Releases
Amcor Flexibles celebrates a dynamic DESICCANT decade at Pharmapack 2017
Amcor’s patented Dessiflex Blister System has been adopted by some of the world’s largest pharma manufacturers.Amcor Flexibles, a world leader in flexible packaging for...
Press Releases
AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance
AbbVie , a global biopharmaceutical company, life-sciences startup Genomics Medicine Ireland Limited (GMI), and WuXi NextCODE, the global contract genomics organization announced the launch...
Production & Manufacturing
Catalent To Develop Softgel Capsules For JOT’s Leading Orphan Disease Candidates
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. ...
News
Alexion Says FDA Grants Orphan Drug Designation To ALXN1210
Alexion Pharmaceuticals Inc announced that the U.S. FDA has granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting anti-C5 antibody that inhibits...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read